Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acrobiosystems CoSZSE:301080 +6.36%91 Days Inventory is 969.06 as of Jun. 2026, which is 22% above its 10-year median of 796.96. GuruFocus rates SZSE:301080 with a GF Score™ of 91/100 and a GF Value™ of ¥57.29 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 642 Biotechnology companies, Acrobiosystems Co ranks worse than 93.46% on this metric.
The historical rank and industry rank for Acrobiosystems Co's Days Inventory or its related term are showing as below:
SZSE:301080'
s Days Inventory Range Over the Past 10 Years
Min: 495.72 Med: 796.96 Max: 1134.63
Current: 1133.9
During the past 9 years, Acrobiosystems Co's highest Days Inventory was 1134.63. The lowest was 495.72. And the median was 796.96.
SZSE:301080's Days Inventory is ranked worse than 93.46% of 642
companies
in the Biotechnology industry
Industry Median: 183.705
vs SZSE:301080: 1133.90
Acrobiosystems Co's Days Inventory
declined
from Jun. 2025 (1,028.59) to Jun. 2026 (969.06).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Acrobiosystems Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Acrobiosystems Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.04.
Acrobiosystems Co (SZSE:301080) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Acrobiosystems Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Acrobiosystems Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Acrobiosystems Co Days Inventory Related Terms
Acrobiosystems Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Acrobiosystems Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:301080 vs VRTX, REGN, MRNA: Days Inventory Comparison
For the Biotechnology subindustry, Acrobiosystems Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acrobiosystems Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Acrobiosystems Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acrobiosystems Co (SZSE:301080) has a Days Inventory of 969.06 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Acrobiosystems Co and its competitors. This is 22% above median its historical median of 796.96. Over the past decade, Acrobiosystems Co's Days Inventory has ranged from 495.72 to 1,134.63. According to the industry distribution chart, Acrobiosystems Co ranks #600 out of 642 companies in the Biotechnology industry, placing it in the top 93.5%.
Is Acrobiosystems Co's Days Inventory too high?
Acrobiosystems Co's current Days Inventory of 969.06 is 22% above median its 10-year median of 796.96. Over the past 10 years, this metric has ranged from a low of 495.72 to a high of 1,134.63. The Biotechnology industry median Days Inventory is 183.71. Acrobiosystems Co's value of 969.06 is 427.5% above this industry median. Based on the distribution chart, Acrobiosystems Co ranks #600 out of 642 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Acrobiosystems Co has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acrobiosystems Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acrobiosystems Co ranks #600 out of 642 companies for Days Inventory. This places Acrobiosystems Co in the lower half of its industry. The industry median Days Inventory is 183.71. Acrobiosystems Co's value of 969.06 is 427.5% above this benchmark. Historically, Acrobiosystems Co's own Days Inventory has ranged from 495.72 to 1,134.63 over the past decade. While the company's 10-year median is 796.96 vs. the industry median of 183.71, Acrobiosystems Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.71, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acrobiosystems Co's current Days Inventory of 969.06 is 427.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Acrobiosystems Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acrobiosystems Co's current Days Inventory is 969.06, which is 22% above median its own 10-year median of 796.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acrobiosystems Co stock overvalued right now?
Based on GuruFocus' analysis, Acrobiosystems Co (SZSE:301080) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥57.29, compared to a current price of ¥84.65 — trading 47.8% above its estimated fair value. The current Days Inventory is 969.06, which is 22% above median its 10-year median of 796.96 and 427.5% above the Biotechnology industry median of 183.71. Acrobiosystems Co's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Acrobiosystems Co (SZSE:301080), the current Days Inventory is 969.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acrobiosystems Co (SZSE:301080) Overvalued in 2026?
Based on GuruFocus' analysis, Acrobiosystems Co stock appears to be overvalued.
The current stock price of ¥84.65 is trading 47.8% above its estimated GF Value™ of ¥57.29.
GuruFocus considers Acrobiosystems Co to be Significantly Overvalued.
Key valuation signals for SZSE:301080:
Days Inventory: 969.06 (22% above median its 10-year median of 796.96)
GF Value™: ¥57.29 vs. price of ¥84.65 (47.8% above fair value)
Industry Position: 427.5% above the Biotechnology median (#600 of 642)
No single metric tells the full story. See the SZSE:301080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.
91GF Score
Get the complete analysis for SZSE:301080
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301080 has been successfully added to your 
